Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital Ruchika Sharma25 Nov 2022 12:15 PM ISTThe funds raised from Ascent will be utilized towards undertaking strategic acquisitions, establishing a best-in-class R&D facility, and ramping up...
FIRST: CSL bags USFDA approval for HEMGENIX to treat hemophilia B Ruchika Sharma25 Nov 2022 11:00 AM ISTHemophilia B is a rare, lifelong bleeding disorder caused by a single gene defect, resulting in insufficient production of factor IX, a protein...
Lupin gets 8 USFDA observations for Mandideep facility Ruchika Sharma25 Nov 2022 11:00 AM ISTMumbai: Lupin has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection with eight observations each...
AbbVie, Teva finalize USD 6.6 billion US opioid settlements Ruchika Sharma24 Nov 2022 4:27 PM ISTUS: Teva Pharmaceutical Industries Ltd and AbbVie Inc have finalized the terms of settlements worth more than $6.6 billion to resolve...
Eli Lilly unveils DCGI approved Ramiven in India for early stage breast cancer Ruchika Sharma24 Nov 2022 4:00 PM ISTRamiven (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
Baxter hospital bed systems recall classified as most serious by USFDA Ruchika Sharma24 Nov 2022 2:30 PM ISTThe device was found to interfere with other nearby critical devices such as infusion pumps, insulin pumps, blood glucose sensors, and bladder...
Cipla gets USFDA OAI status for Goa facility Ruchika Sharma24 Nov 2022 1:30 PM ISTMumbai: Pharma major Cipla has announced that the company has received a communication from the US Food and Drug Administration (USFDA) that the...
USFDA inspection: Glenmark Pharma gets warning letter for Goa facility Ruchika Sharma24 Nov 2022 12:30 PM ISTMumbai: Drugmaker Glenmark Pharma has recently announced that the US Food and Drug Administration (USFDA) has issued a warning letter to the...
Aurobindo Pharma USA arm, Evive Biotech ink pact for commercialisation of Ryzneuta in US Ruchika Sharma24 Nov 2022 11:15 AM ISTThis important partnership builds on the comprehensive global development program of Ryzneuta, which includes 12 clinical trials and has enrolled over...
Takeda Dengue Vaccine TAK-003 gets USFDA priority review Ruchika Sharma23 Nov 2022 5:00 PM ISTTakeda's tetravalent dengue vaccine candidate (TAK-003) is based on a live-attenuated dengue serotype 2 virus, which provides the genetic "backbone"...
USFDA nod to Zydus Lifesciences Famotidine Injection Ruchika Sharma23 Nov 2022 4:16 PM ISTFamotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have...
Indian Pharma exports grow by 138 percent since 2013-14 Ruchika Sharma23 Nov 2022 3:09 PM ISTNew Delhi: India's pharma exports have increased 138 percent in April-October 2022-23 compared to the same period of 2013-14 when the country became...
